These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26956861)

  • 21. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy.
    Cooney R; Scott JR; Mahowald M; Langen E; Sharma G; Kao DP; Davis MB
    Clin Cardiol; 2022 Feb; 45(2):205-213. PubMed ID: 35129215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
    Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
    ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
    Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D
    ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial.
    Biteker M; Duran NE; Kaya H; Gündüz S; Tanboğa HÎ; Gökdeniz T; Kahveci G; Akgün T; Yildiz M; Õzkan M
    Clin Res Cardiol; 2011 Jul; 100(7):571-7. PubMed ID: 21197536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.
    Duncker D; Westenfeld R; Konrad T; Pfeffer T; Correia de Freitas CA; Pfister R; Thomas D; Fürnkranz A; Andrié RP; Napp A; Schmitt J; Karolyi L; Wakili R; Hilfiker-Kleiner D; Bauersachs J; Veltmann C
    Clin Res Cardiol; 2017 Aug; 106(8):582-589. PubMed ID: 28275862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frequency and predictors of recovery of normal left ventricular ejection fraction and end-diastolic diameter in patients with dilated cardiomyopathy].
    Zou C; Wu X; Zhou Q; Zhang Y; Lyu R; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):851-5. PubMed ID: 25547449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.
    Fett JD; Christie LG; Carraway RD; Murphy JG
    Mayo Clin Proc; 2005 Dec; 80(12):1602-6. PubMed ID: 16342653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to heart failure treatment in patients with peripartum cardiomyopathy.
    Hoevelmann J; Sliwa K; Schaar JM; Briton O; Böhm M; Meyer MR; Viljoen C
    ESC Heart Fail; 2024 Jun; 11(3):1677-1687. PubMed ID: 38439175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy.
    Briasoulis A; Mocanu M; Marinescu K; Qaqi O; Palla M; Telila T; Afonso L
    Echocardiography; 2016 Sep; 33(9):1354-60. PubMed ID: 27342869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discoveries in peripartum cardiomyopathy.
    Fett JD; Markham DW
    Trends Cardiovasc Med; 2015 Jul; 25(5):401-6. PubMed ID: 25557957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Imran TF; Mohebali D; Lopez D; Goli RR; DeFilippis EM; Truong S; Bello NA; Gaziano JM; Djousse L; Coglianese EE; Feinberg L; Wu WC; Choudhary G; Arany Z; Kociol R; Sabe MA
    Int J Cardiol; 2022 Jun; 357():48-54. PubMed ID: 35358637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis.
    Hosseinpour A; Hosseinpour H; Kheshti F; Abdollahifard S; Attar A
    ESC Heart Fail; 2022 Oct; 9(5):3483-3495. PubMed ID: 35883253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
    Mujkanovic J; Qayyum AA
    Curr Cardiol Rev; 2023; 19(2):e230822207933. PubMed ID: 36017853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
    Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
    Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular recovery in an African cohort of patients with peripartum cardiomyopathy.
    Dangwé Temoua N; Bamouni J; Mandi DG; Kaboré E; Allawaye L; Langtar MH; Adjougoulta A; Douné N; Adam A; Zakaria A; Rélwendé Aristide Y; Yibar K; Kologo KJ; Millogo GRC; Yaméogo NV; Zabsonré P
    Pan Afr Med J; 2024; 47():6. PubMed ID: 38371651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy.
    Ntusi NB; Badri M; Gumedze F; Sliwa K; Mayosi BM
    PLoS One; 2015; 10(8):e0133466. PubMed ID: 26252951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy.
    Barasa A; Goloskokova V; Ladfors L; Patel H; Schaufelberger M
    J Matern Fetal Neonatal Med; 2018 May; 31(10):1342-1349. PubMed ID: 28462600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and outcome of peripartum cardiomyopathy in Malaysia.
    Chee KH; Azman W
    Int J Clin Pract; 2009 May; 63(5):722-5. PubMed ID: 18028390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.